Back to Search
JEFFREY MEYERHARDT, MD MPH
MD MPH
Medical Oncology Physician
NPI: 1548238710IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
203798(MA)
Education
YALE UNIVERSITY SCHOOL OF MEDICINE
Class of 1997
Research & Publications (20)
Phase-II study of gemcitabine and cisplatin in patients with metastatic biliary and gallbladder cancer.
PMID 17597402·Dig Dis Sci·2008
3-trial
Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cancer and Leukemia Group B 89803.
PMID 18757324·J Clin Oncol·2008
2-rct
Phase I study of gefitinib, irinotecan, 5-fluorouracil and leucovorin in patients with metastatic colorectal cancer.
PMID 17216531·Cancer Chemother Pharmacol·2007
3-trial
Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer.
PMID 17699009·JAMA·2007
8-other
Phase II study of FOLFOX, bevacizumab and erlotinib as first-line therapy for patients with metastatic colorectal cancer.
PMID 17483115·Ann Oncol·2007
3-trial
Physical activity and survival after colorectal cancer diagnosis.
PMID 16822844·J Clin Oncol·2006
8-other
Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803.
PMID 16822843·J Clin Oncol·2006
8-other
Efficacy of cetuximab after treatment with oral epidermal growth factor receptor tyrosine kinase inhibitor-based chemotherapy in metastatic colorectal cancer.
PMID 16796793·Clin Colorectal Cancer·2006
3-trial
Phase II study of capecitabine, oxaliplatin, and erlotinib in previously treated patients with metastastic colorectal cancer.
PMID 16622264·J Clin Oncol·2006
3-trial
Assessment of a dietary questionnaire in cancer patients receiving cytotoxic chemotherapy.
PMID 16293876·J Clin Oncol·2005
8-other
Associations between plasma insulin-like growth factor proteins and C-peptide and quality of life in patients with metastatic colorectal cancer.
PMID 15941948·Cancer Epidemiol Biomarkers Prev·2005
8-other
Epidermal growth factor receptor inhibitors and colorectal cancer.
PMID 15685832·Oncology (Williston Park)·2004
6-review
Relationship of baseline serum bilirubin to efficacy and toxicity of single-agent irinotecan in patients with metastatic colorectal cancer.
PMID 15084617·J Clin Oncol·2004
8-other
Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114.
PMID 14966087·J Clin Oncol·2004
8-other
Impact of hospital procedure volume on surgical operation and long-term outcomes in high-risk curatively resected rectal cancer: findings from the Intergroup 0114 Study.
PMID 14701779·J Clin Oncol·2004
8-other
Association of hospital procedure volume and outcomes in patients with colon cancer at high risk for recurrence.
PMID 14568853·Ann Intern Med·2003
3-trial
Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma.
PMID 12879464·Cancer·2003
3-trial
Follow-up strategies after curative resection of colorectal cancer.
PMID 12870136·Semin Oncol·2003
6-review
Adjuvant therapy in gastric cancer: can we prevent recurrences?
PMID 12800796·Oncology (Williston Park)·2003
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 44 BINNEY ST, DANA-FARBER CANCER INST
BOSTON, MA 02115 - Phone
- (617) 632-6855
Quick Facts
- NPI
- 1548238710
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 29
- Publications
- 20
Are you this provider?
Claim Your Profile